Skip to Main Content

Paper Details

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database.
Eur J Cancer
5
2020
Author NameAffiliation
Eleni EfstathiouAlexandra Hospital, University of Athens, The University of Texas MD Anderson Cancer Center
Amit BahlUniversity Hospitals Bristol NHS Foundation Trust
  • 1 - 2

Datasets